← Back to Search

Sildenafil 25mg Oral Tablet for Prostate Cancer

Phase 3
Waitlist Available
Led By Kuwong B Mwamukonda, MD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post surgery
Awards & highlights

Summary

This trial will compare the effectiveness of two drugs in helping men regain erectile function after surgery for prostate cancer.

Eligible Conditions
  • Prostate Cancer
  • Erectile Dysfunction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Erectile function
Secondary study objectives
Penile length

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Sildenafil 25mg Oral TabletActive Control1 Intervention
25mg sildenafil citrate twice daily
Group II: PentoxifyllineActive Control1 Intervention
400mg pentoxifylline twice daily
Group III: PlaceboPlacebo Group1 Intervention
placebo twice daily

Find a Location

Who is running the clinical trial?

Walter Reed National Military Medical CenterFED
139 Previous Clinical Trials
32,983 Total Patients Enrolled
1 Trials studying Prostate Cancer
8 Patients Enrolled for Prostate Cancer
Brooke Army Medical CenterLead Sponsor
127 Previous Clinical Trials
26,600 Total Patients Enrolled
Kuwong B Mwamukonda, MDPrincipal Investigator - Brooke Army Medical Center
Brooke Army Medical Center
~21 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top